Nephrology

Dr. George Bakris, MD, is a referral nephrologist, board-certified hypertension specialist, and professor of medicine and director of ASH Comprehensive Hypertension Center at The University of Chicago. He specializes in kidney disease as it relates to diabetes and blood pressure issues. In this interview, Dr. Bakris shares his excitement for the results of some important diabetes trials.

Dr. George Bakris shares his suggestions for reducing kidney disease risk in a talk with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego.

Dr. George Bakris talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the links between cardiovascular and kidney diseases.

Dr. George Bakris talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the increase of people on dialysis due to increase in kidney disease but decrease in cardiovascular mortality.

Dr. George Bakris talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the possible kidney benefits for those using SGLT-2s.

Dr. George Bakris talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about what he is looking forward to in the results of some promising diabetes trials.

Dr. Matthew Weir discusses the pros and cons of SGLT-2 drugs with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas. Dr. Matthew Weir, MD is a professor of medicine and director of Nephrology in the Department of Medicine at the University of Maryland. Dr. …

Dr. Matthew Weir talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the impact of SGLT2 drugs on the possible improvement of kidney disease. Dr. Matthew Weir, MD is a professor of medicine and director of Nephrology in the Department of Medicine …

At the the AACE 2017 convention in Austin, Texas, Dr. Matthew Weir and Diabetes in Control Publisher Steve Freed discuss the impact of SGLT2 drugs in helpful as well as possibly harmful ways. They also look at the need for safety studies for kidney disease. Dr. Matthew Weir, MD is …

At the AACE 2017 convention in Austin, Texas, Dr. Matthew Weir talks with Diabetes in Control Publisher Steve Freed about how he detects kidney disease in an effort to catch and treat the condition in its early stages. Dr. Matthew Weir, MD is a professor of medicine and director of …